Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshima Z Parris

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Genes, Chromosomes & Cancer|April 3, 2019
Radiation-induced genomic instability in breast carcinomas of the Swedish hemangioma cohortJana Biermann, Britta Langen, Szilárd Nemes, et al.
Nuclear Medicine and Biology|March 5, 2018
Time-dependent transcriptional response of GOT1 human small intestine neuroendocrine tumor after <sup>177</sup>Lu[Lu]-octreotate therapyJohan Spetz, Nils Rudqvist, Britta Langen, et al.
BMC Cancer|March 2, 2019
The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004-2014)Shahin De Lara, Jenny Nyqvist, Elisabeth Werner Rönnerman, et al.
The Lancet. Healthy Longevity|September 12, 2022
Adjuvant chemotherapy and survival in women aged 70 years and older with triple-negative breast cancer: a Swedish population-based propensity score-matched analysisSlavica Janeva, Chenyang Zhang, Anikó Kovács, et al.
BMC Cancer|September 20, 2019
Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomasHanna Engqvist, Toshima Z Parris, Anikó Kovács, et al.
Breast Cancer Research : BCR|August 11, 2018
Clonal relatedness in tumour pairs of breast cancer patientsJana Biermann, Toshima Z Parris, Szilárd Nemes, et al.
Translational Oncology|August 13, 2025
Novel gene rearrangement leads to altered expression of Hornerin in sensitive and chemoresistant ovarian cancerGhassan M Saed, Harvey Sharma, Jenna Dabaja, et al.
EJNMMI Research|March 22, 2019
Transcriptional effects of <sup>177</sup>Lu-octreotate therapy using a priming treatment schedule on GOT1 tumor in nude miceJohan Spetz, Britta Langen, Nils-Petter Rudqvist, et al.
Journal of Ovarian Research|January 28, 2026
Proteomic analysis of ovarian carcinoma reveals diagnostic and prognostic biomarkers with histotype- and stage-specificityLucas Werner, Ella Ittner, Hugo Swenson, et al.
Oncotarget|November 13, 2018
Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survivalHanna Engqvist, Toshima Z Parris, Elisabeth Werner Rönnerman, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Genes, Chromosomes & Cancer|April 3, 2019
Radiation-induced genomic instability in breast carcinomas of the Swedish hemangioma cohortJana Biermann, Britta Langen, Szilárd Nemes, et al.
Nuclear Medicine and Biology|March 5, 2018
Time-dependent transcriptional response of GOT1 human small intestine neuroendocrine tumor after <sup>177</sup>Lu[Lu]-octreotate therapyJohan Spetz, Nils Rudqvist, Britta Langen, et al.
BMC Cancer|March 2, 2019
The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004-2014)Shahin De Lara, Jenny Nyqvist, Elisabeth Werner Rönnerman, et al.
The Lancet. Healthy Longevity|September 12, 2022
Adjuvant chemotherapy and survival in women aged 70 years and older with triple-negative breast cancer: a Swedish population-based propensity score-matched analysisSlavica Janeva, Chenyang Zhang, Anikó Kovács, et al.
BMC Cancer|September 20, 2019
Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomasHanna Engqvist, Toshima Z Parris, Anikó Kovács, et al.
Breast Cancer Research : BCR|August 11, 2018
Clonal relatedness in tumour pairs of breast cancer patientsJana Biermann, Toshima Z Parris, Szilárd Nemes, et al.
Translational Oncology|August 13, 2025
Novel gene rearrangement leads to altered expression of Hornerin in sensitive and chemoresistant ovarian cancerGhassan M Saed, Harvey Sharma, Jenna Dabaja, et al.
EJNMMI Research|March 22, 2019
Transcriptional effects of <sup>177</sup>Lu-octreotate therapy using a priming treatment schedule on GOT1 tumor in nude miceJohan Spetz, Britta Langen, Nils-Petter Rudqvist, et al.
Journal of Ovarian Research|January 28, 2026
Proteomic analysis of ovarian carcinoma reveals diagnostic and prognostic biomarkers with histotype- and stage-specificityLucas Werner, Ella Ittner, Hugo Swenson, et al.
Oncotarget|November 13, 2018
Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survivalHanna Engqvist, Toshima Z Parris, Elisabeth Werner Rönnerman, et al.
Pageof 8